TLR4 and fungal keratitis: SAHA was able to inhibit experimental fungal keratitis by suppressing TLR4 and inflammatory cytokines (TNFα, IL-1β) and inhibition of HDAC may be a potential therapeutic approach for the treatment of fungal keratitis.